Drug Profile
Furosemide - Cutanea Life Sciences
Alternative Names: CLS 006Latest Information Update: 05 Nov 2021
Price :
$50
*
At a glance
- Originator Cutanea Life Sciences
- Class Antihypertensives; Heart failure therapies; Skin disorder therapies; Small molecules; Sulfanilamides
- Mechanism of Action Loop diuretics; Sodium-potassium-chloride symporter inhibitors; Symporter inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Warts
Most Recent Events
- 07 Nov 2018 Cutanea Life Sciences completes a phase III trial in Warts (In children, In adolescents, In adults, In the elderly) in USA (Topical) (NCT03259620)
- 19 Jul 2018 Cutanea Life Sciences completes a phase III trial in Warts (In adolescents, In adults, In the elderly) in USA (NCT02971891)
- 01 Sep 2017 Phase-III clinical trials in Warts (In children) in USA (Topical) (NCT03259620)